 Deals were put on hold, investor meetings canceled, and fundraising schedules postponed as market participants faced a health crisis of unprecedented reach and magnitude. Healthcare companies such as Bausch Health and Pharmaceutical Product Development PPD, as well as British technology firm Micro Focus pulled transactions as the borrower-friendly market all but vanished. 